Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Pharmacokinetics and RP2D analysis from ETCTN 10388: A phase I trial of triapine and lutetium Lu-177 dotatate in well-differentiated somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Authors
Aman Chauhan
UK Markey Cancer Center, University of Kentucky, Lexington, KY;
Aman Chauhan , Susan M. Christner , Jan Hendrik Beumer , Charles Kunos , Aman Khurana , Riham El Khouli , Heidi Weiss , Donglin Yan , Heloisa P. Soares , Thorvardur Ragnar Halfdanarson , Daneng Li , William Edgar Carson III, Mark B Evers , Percy Ivy , Elise C. Kohn , Larry Rubinstein , Susanne M. Arnold , Jill Kolesar , Lowell Brian Anthony , Bhavana Konda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
04234568
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 648)
DOI
10.1200/JCO.2023.41.4_suppl.648
Abstract #
648
Poster Bd #
G17
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Etctn 10388: A phase I trial of triapine and lutetium Lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Aman Chauhan
Poster
2015 ASCO Annual Meeting
Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.
First Author: Jennifer Rachel Eads
Poster
2023 ASCO Annual Meeting
A phase I study of nanoparticle albumin-bound sirolimus (NAB-S) combined with pazopanib (PAZO) in patients with advanced soft tissue sarcoma (STS).
First Author: Lee D. Cranmer
Poster
2023 ASCO Annual Meeting
Phase 1 study of indenoisoquinoline LMP744 in adults with relapsed solid tumors and lymphomas.
First Author: Brian Ko